R. M. Austin

发表

G. Meyer, R. M. Austin, C. E. Brady, 1986, Journal of clinical gastroenterology.

Individualized Bayesian Risk Assessment for Cervical Squamous Neoplasia

R. M. Austin, Lama Farchoukh, A. Onisko, 2020, Journal of pathology informatics.

Enhanced Detection of Cervical Cancer and Precancer Through Use of Imaged Liquid-Based Cytology in Routine Cytology and HPV Cotesting

Chengquan Zhao, R. M. Austin, A. Onisko, 2018, American journal of clinical pathology.

Application of Bayesian network modeling to pathology informatics

Marek J Druzdzel, R. M. Austin, A. Onisko, 2018, Diagnostic cytopathology.

The Pittsburgh Cervical Cancer Screening Model: a risk assessment tool.

Marek J Druzdzel, R. M. Austin, A. Onisko, 2010, Archives of pathology & laboratory medicine.

Application of Dynamic Bayesian Networks to cervical cancer screening

Marek J Druzdzel, R. M. Austin, A. Onisko, 2009 .

Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?

Chengquan Zhao, R. M. Austin, A. Onisko, 2020, Journal of the American Society of Cytopathology.

Results of blinded rescreening of Papanicolaou smears versus biased retrospective review.

R. M. Austin, 1997, Archives of pathology & laboratory medicine.

Nationwide survey of cervical cytology laboratory practices in China.

Chengquan Zhao, R. M. Austin, Jian-hua Zhou, 2019, Journal of the American Society of Cytopathology.

Is 58% sensitivity for detection of cervical intraepithelial neoplasia 3 and invasive cervical cancer optimal for cervical screening?

Chengquan Zhao, R. M. Austin, 2014, CytoJournal.

The role of monitoring interpretive rates, concordance between cytotechnologist and pathologist interpretations before sign-out, and turnaround time in gynecologic cytology quality assurance: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference wo

J. Tworek, R. M. Austin, D. Davey, 2013, Archives of pathology & laboratory medicine.

Histopathologic Outcomes and Clinical Correlations for High-Risk Patients Screened with Anal Cytology

Chengquan Zhao, R. M. Austin, A. Domfeh, 2012, Acta Cytologica.

Follow-up outcomes in a large cohort of patients with human papillomavirus-negative ASC-H cervical screening test results.

Chengquan Zhao, R. M. Austin, David A Cohen, 2012, American journal of clinical pathology.

The Papanicolaou Smear: Medicine's Most Successful Cancer Screening Procedure Is Threatened

R. M. Austin, W. W. McLendon, 1997 .

Test group biases and ethical concerns mar New England Journal of Medicine articles promoting HPV screening for cervical cancer in rural India

Chengquan Zhao, R. M. Austin, 2009, CytoJournal.

Prevalence of High-Risk Human Papillomavirus Infection in China: Analysis of 671,163 Human Papillomavirus Test Results From China's Largest College of American Pathologists-Certified Laboratory.

Chengquan Zhao, R. M. Austin, Baowen Zheng, 2016, American journal of clinical pathology.

Ultrasound Guided Core Biopsy versus Fine Needle Aspiration for Evaluation of Axillary Lymphadenopathy in Patients with Breast Cancer

Andriy I. Bandos, Amy E. Kelly, Gordon Abrams, 2014, ISRN oncology.

Use of Uterine Characteristics to Improve Fertility-Sparing Diagnosis of Adenomyosis.

R. M. Austin, N. Donnellan, Ted Lee, 2018, Journal of gynecologic surgery.

Risk-based cervical screening guidelines should utilize large diverse national database and specifically measure invasive cancer risk of screened patients

Chengquan Zhao, R. M. Austin, 2021 .

Cotesting in Cervical Cancer Screening

R. M. Austin, J. Andrews, A. Onisko, 2020, American journal of clinical pathology.

The impact of primary HPV screening on the incidence of cervical cancer in New Zealand.

R. M. Austin, B. Cox, M. Sneyd, 2019, Journal of the American Society of Cytopathology.

Significance of Human Papillomavirus Test Performance in Samples From Women With Histopathologically Confirmed Invasive Cervical Cancer.

Chengquan Zhao, R. M. Austin, A. Olawaiye, 2016, Journal of lower genital tract disease.

Follow-up findings in young females with high-grade squamous intraepithelial lesion papanicolaou test results.

Chengquan Zhao, R. M. Austin, Pal Kalposi-Novak, 2011, Archives of pathology & laboratory medicine.

Cervical Stenosis: Previously Unrecognized Cause of False-Negative Human Papillomavirus Tests in Women Developing Cervical Cancer

Chengquan Zhao, R. M. Austin, S. Satturwar, 2020, Journal of lower genital tract disease.

Cervical Cytology Specimen Adequacy: Patient Management Guidelines and Optimizing Specimen Collection

J. T. Cox, L. Howell, G. Birdsong, 2008, Journal of lower genital tract disease.

The impact of the Clinical Laboratory Improvement Amendments of 1988 on cytopathology practice: a 25th anniversary review.

G. Birdsong, R. M. Austin, D. Davey, 2014, Journal of the American Society of Cytopathology.

PPV of an HSIL cervical cytology result in China's largest CAP-certified laboratory.

Chengquan Zhao, R. M. Austin, Zaibo Li, 2015, Journal of the American Society of Cytopathology.

Aptima HPV messenger RNA testing and histopathologic follow‐up in women with HSIL cytology: A study emphasizing additional review of HPV‐negative cases

Chengquan Zhao, R. M. Austin, Huina Zhang, 2021, Cancer cytopathology.

Type 1 and type 2 cervical carcinomas: some cervical cancers are more difficult to prevent with screening

R. M. Austin, C. Zhao, 2012, Cytopathology : official journal of the British Society for Clinical Cytology.

Unrecognized risks associated with new cervical screening guidelines for younger women.

Chengquan Zhao, R. M. Austin, 2011, Archives of pathology & laboratory medicine.

Medicolegal Affairs

W. Frable, L. Koss, R. M. Austin, 1998, Acta Cytologica.

The promise and risk of a new technology

R. M. Austin, D. Beckwith, W. Dupree, 1998, Cancer.

Intussusception and total body opacification.

R. M. Austin, K. McCarten, S. Borden, 1980, Clinical radiology.

Scientific issues related to the cytology proficiency testing regulations

Brenda L. Schultz, M. Bibbo, L. Howell, 2006, Acta Cytologica.

Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic womens hospital laboratory employing sensitive screening methods.

Chengquan Zhao, R. M. Austin, A. Onisko, 2009, Gynecologic oncology.

Multicentric adult secretory breast carcinoma: DNA flow cytometric findings, prognostic features, and review of the world literature

R. M. Austin, G. Richard, J. Hawk, 1990, Journal of surgical oncology.

HPV Test Results Stratify Risk for Histopathologic Follow-Up Findings of High-Grade Cervical Intra-Epithelial Neoplasia in Women with Low-Grade Squamous Intra-Epithelial Lesion Pap Results

Chengquan Zhao, R. M. Austin, A. Heider, 2010, Acta Cytologica.

Follow-up findings for women with human papillomavirus-positive and atypical squamous cells of undetermined significance screening test results in a large women's hospital practice.

Chengquan Zhao, D. Dabbs, R. M. Austin, 2009, Archives of pathology & laboratory medicine.

Brush cytology of the fallopian tube and implications in ovarian cancer screening.

R. M. Austin, Ted Lee, S. Mansuria, 2014, Journal of minimally invasive gynecology.

Vaginal Cytology Results in Follow-up of Endometrial Carcinoma After Hysterectomy.

Chengquan Zhao, R. M. Austin, A. Karunamurthy, 2016, American journal of clinical pathology.

Cytomorphology of Crystal Storing Histiocytosis in the Breast Associated with Lymphoma: A Case Report

S. Monaco, R. M. Austin, W. Khalbuss, 2011, Acta Cytologica.

Prevalence of HPV 16/18 genotypes and histopathologic follow-up outcomes in women with negative cytology and positive high-risk HPV test results.

Chengquan Zhao, R. M. Austin, Zaibo Li, 2015, Journal of the American Society of Cytopathology.

Anatomic Pathology / Screening for Cervical Glandular Neoplasia

Chengquan Zhao, R. M. Austin, Zaibo Li, 2013 .

Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.

Chengquan Zhao, R. M. Austin, A. Heider, 2010, Archives of pathology & laboratory medicine.

Computer‐assisted Papanicolaou imaging

R. M. Austin, 2010, Cancer cytopathology.

Adjunctive high‐risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample

Chengquan Zhao, R. M. Austin, 2008, Cancer.

Gas collections in the spinal cord on computed tomography.

R. M. Austin, B. Carter, M. Bankoff, 1981, Journal of computer assisted tomography.

American society of cytopathology workload recommendations for automated pap test screening: Developed by the productivity and quality assurance in the era of automated screening task force

A. Renshaw, A. Moriarty, R. M. Austin, 2013, Diagnostic cytopathology.

Inception and Development of the Papanicolaou Stain Method

Maheswari S. Mukherjee, M. Boon, R. M. Austin, 2017, Acta Cytologica.

Scientific issues related to the cytology proficiency testing regulations.

R. Marshall Austin, Dina R. Mody, George G. Birdsong, 2006, Acta cytologica.

Pap Test Reporting Rates for Conventional Smear and Liquid-Based Cervical Cytology from the Largest Academic Women's Hospital in China: Analysis of 1,248,785 Pap Test Reports

Chengquan Zhao, R. M. Austin, X. Tao, 2015, Acta Cytologica.

Fine needle aspiration is a feasible and accurate technique in the diagnosis of lymphoma.

G. Birdsong, R. M. Austin, D. Kaminsky, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation and significance of hyperchromatic crowded groups (HCG) in liquid-based paps

R. M. Austin, M. Chivukula, V. Shidham, 2007, CytoJournal.

Cytologic Findings in Experimental in vivo Fallopian Tube Brush Specimens

R. M. Austin, E. Rodriguez, D. Lum, 2013, Acta Cytologica.

Expert review of histologic slides and Papanicolaou tests in the context of litigation or potential litigation. Surgical Pathology Committee and Cytopathology Committee of the College of American Pathologists.

R. M. Austin, P. Fitzgibbons, 2000, Archives of pathology & laboratory medicine.

Computed tomography of axillary and supraclavicular adenopathy.

R. Goldberg, R. M. Austin, 1985, Clinical radiology.

Follow-up outcomes of a large cohort of low-risk women with negative imaged liquid-based cytology and negative HPV test results.

Chengquan Zhao, R. M. Austin, Zaibo Li, 2013, American journal of clinical pathology.

The Role of High-Risk Human Papilloma Virus Testing in the Surveillance of Cervical Cancer After Treatment.

R. M. Austin, S. Beriwal, J. Kelley, 2015, Archives of pathology & laboratory medicine.

Human papillomavirus testing and cytologic/histopathologic "test of cure" follow-up results after excisional treatment for high-grade cervical intraepithelial neoplasia.

Chengquan Zhao, R. M. Austin, Zaibo Li, 2014, Journal of the American Society of Cytopathology.

Low-grade squamous intraepithelial lesion/cannot exclude high-grade squamous intraepithelial lesion (LSIL-H) is a unique category of cytologic abnormality associated with distinctive HPV and histopathologic CIN 2+ detection rates.

Chengquan Zhao, R. M. Austin, Zaibo Li, 2014, American journal of clinical pathology.

Cholecystojejunostomy intussusception

R. M. Austin, Ducksoo Kim, D. Porter, 2005, Gastrointestinal Radiology.

Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results.

Chengquan Zhao, D. Dabbs, R. M. Austin, 2008, Archives of pathology & laboratory medicine.

Heavy Cervical Cancer Burden in Elderly Women: How Can We Improve the Situation?

R. M. Austin, T. Krivak, R. Edwards, 2012, Acta Cytologica.

Atypical Squamous Cells, Cannot Exclude High-Grade Squamous Intraepithelial Lesion: Review of Ancillary Testing Modalities and Implications for Follow-up

M. Husain, R. M. Austin, D. Davey, 2010, Journal of lower genital tract disease.

HPV test results provide useful risk stratification information in women with ASC‐H Pap test findings

Chengquan Zhao, R. M. Austin, 2016, Cancer cytopathology.

Follow-up outcomes in a large cohort of patients with HPV-negative LSIL cervical screening test results.

Chengquan Zhao, R. M. Austin, Zaibo Li, 2015, American journal of clinical pathology.

Cytology and human papillomavirus screening test results associated with 2827 histopathologic diagnoses of cervical intraepithelial neoplasia 2/3.

Chengquan Zhao, R. M. Austin, A. Kanbour‐Shakir, 2013, Archives of pathology & laboratory medicine.

Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.

Chengquan Zhao, M. Guo, R. M. Austin, 2012, Archives of pathology & laboratory medicine.

Histopathologic follow‐up and human papillomavirus DNA test results in 290 patients with high–grade squamous intraepithelial lesion papanicolaou test results

Chengquan Zhao, R. M. Austin, Faye F. Gao, 2011, Cancer cytopathology.

Follow-up outcomes for a large cohort of US women with negative imaged liquid-based cytology findings and positive high risk human papillomavirus test results.

Chengquan Zhao, R. M. Austin, A. Onisko, 2011, Gynecologic oncology.

High-risk HPV DNA detected in less than 2% of over 25,000 cytology negative imaged liquid-based Pap test samples from women 30 and older.

Chengquan Zhao, R. M. Austin, M. Bansal, 2009, Gynecologic oncology.

Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone.

Chengquan Zhao, R. M. Austin, 2007, Gynecologic oncology.

What Role Should Cytology Play in Cervical Cancer Screening?

Chengquan Zhao, D. Saslow, R. M. Austin, 2019, Journal of lower genital tract disease.

Market survey predictions on the future of US Pap testing

I. Ramzy, S. Bigner, G. Freund, 2009, CytoJournal.

Abdominopelvic washings: A comprehensive review

L. Pantanowitz, S. Monaco, R. M. Austin, 2013, CytoJournal.

Reply to comparison of cervical cancer screening results among 256,648 women in multiple clinical practices

R. M. Austin, R. Luff, R. Kennedy, 2015, Cancer cytopathology.

Digital Applications in Cytopathology: Problems, Rationalizations, and Alternative Approaches

Maheswari S. Mukherjee, L. Pantanowitz, R. M. Austin, 2017, Acta Cytologica.

Correlation of histopathologic follow-up findings with vaginal human papillomavirus and low-grade squamous intraepithelial lesion Papanicolaou test results.

Chengquan Zhao, R. M. Austin, M. Bansal, 2011, Archives of pathology & laboratory medicine.

Risk stratification for cervical neoplasia using extended high‐risk HPV genotyping in women with ASC‐US cytology: A large retrospective study from China

Chengquan Zhao, L. Sui, R. M. Austin, 2021, Cancer cytopathology.

College of American Pathologists Conference XXX on quality and liability issues with the Papanicolaou smear: summation.

R. M. Austin, 1997, Archives of Pathology & Laboratory Medicine.

Human papillomavirus reporting: minimizing patient and laboratory risk.

R. M. Austin, 2003, Archives of pathology & laboratory medicine.

The Clinical Utility of Extended High-Risk HPV Genotyping in Women With ASC-US Cytology.

Chengquan Zhao, R. M. Austin, Huina Zhang, 2022, American journal of clinical pathology.

Observations From Pap Litigation Consultations

Chengquan Zhao, R. M. Austin, 2011 .

Clinical utility of adjunctive high-risk human papillomavirus DNA testing in women with Papanicolaou test findings of atypical glandular cells.

Chengquan Zhao, R. M. Austin, Anca V. Florea, 2010, Archives of pathology & laboratory medicine.

Cervical screening test results associated with 265 histopathologic diagnoses of cervical glandular neoplasia.

Chengquan Zhao, R. M. Austin, Zaibo Li, 2013, American journal of clinical pathology.

Negative Predictive Value and Significance of Benign-Appearing Endometrial Cells in Papanicolaou Tests

R. M. Austin, A. Onisko, Jing Yu, 2017, American journal of clinical pathology.

Medicolegal affairs. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.

W. Frable, L. Koss, R. M. Austin, 1998, Acta cytologica.

How to interpret the results of medical time series data analysis: Classical statistical approaches versus dynamic Bayesian network modeling

Marek J. Druzdzel, Agnieszka Onisko, Marek J Druzdzel, 2016, Journal of pathology informatics.

Medicolegal affairs: IAC task force summary

W. Frable, L. Koss, R. M. Austin, 1998 .

The Papanicolaou smear. Medicine's most successful cancer screening procedure is threatened.

R. M. Austin, W. W. McLendon, 1997, JAMA.

Contributions of Liquid-Based (Papanicolaou) Cytology and Human Papillomavirus Testing in Cotesting for Detection of Cervical Cancer and Precancer in the United States

R. M. Austin, A. Onisko, Zhen Chen, 2020, American journal of clinical pathology.

Exhortations to abandon the Pap test as a routine initial cervical screening test are still premature and carry significant risks

R. M. Austin, 2010, Diagnostic cytopathology.

High-Risk Human Papillomavirus DNA Test Results Are Useful for Disease Risk Stratification in Women With Unsatisfactory Liquid-Based Cytology Pap Test Results

Chengquan Zhao, R. M. Austin, 2009, Journal of lower genital tract disease.

ASCCP patient management guidelines: Pap test specimen adequacy and quality indicators.

J. T. Cox, M. Henry, G. Birdsong, 2002, American journal of clinical pathology.

ASCCP Patient Management Guidelines: Pap Test Specimen Adequacy and Quality Indicators

J. T. Cox, M. Henry, G. Birdsong, 2002, Journal of lower genital tract disease.

Managing risk in gynecologic cytology: reactive and unsatisfactory smears.

R. M. Austin, 1997, Cancer.

Follow-up of Women With Negative Pap Test Results and Abnormal Clinical Signs or Symptoms.

R. M. Austin, Rebecca Ocque, 2016, American journal of clinical pathology.

Point-Counterpoint: Cervical Cancer Screening Should Be Done by Primary Human Papillomavirus Testing with Genotyping and Reflex Cytology for Women over the Age of 25 Years

Chengquan Zhao, M. Stoler, R. M. Austin, 2015, Journal of Clinical Microbiology.

College of American Pathologists Conference XXX on quality and liability issues with the Papanicolaou smear: introduction.

R. M. Austin, 1997, Archives of pathology & laboratory medicine.

Routine endometrial sampling of asymptomatic premenopausal women shedding normal endometrial cells in papanicolaou tests is not cost effective

D. Dabbs, Susan White, R. M. Austin, 2007, Cancer.

The Detection of Precancerous Cervical Lesions Can Be Significantly Increased Who Cares and Who Should Know

R. M. Austin, 2009 .

What Constitutes Optimal Cervical Screening for Young Women Ages 21 to 29 Years?

Chen Zhao, R. M. Austin, 2020, American journal of clinical pathology.

Comparison of Cervical Cancer Screening Results Among 256,648 Women in Multiple Clinical Practices

R. M. Austin, R. Luff, Ronald D Luff, 2015, Cancer cytopathology.

Cervical cytology practice guideline. American Society of Cytopathology.

A. Renshaw, A. Moriarty, J. Bishop, 2001, Diagnostic Cytopathology.

Histopathologic follow‐up and HPV test results with HSIL Papanicolaou test results in China's largest academic women's hospital

H. Zhang, Chengquan Zhao, R. M. Austin, 2017, Cancer cytopathology.

Nationwide Prevalence and Genotype Distribution of High-Risk Human Papillomavirus Infection in China.

Chengquan Zhao, R. M. Austin, Baowen Zheng, 2021, American journal of clinical pathology.

The coming human papillomavirus (HPV) test-driven colposcopy tsunami.

R. M. Austin, 2017, Journal of the American Society of Cytopathology.

Gas Collections in the Spinal Canal on Computed Tomography

R. M. Austin, B. Carter, M. Bankoff, 1981 .

Whose cervical screening model predictions will prove to be correct?

R. M. Austin, A. Herbert, 2018, Journal of the American Society of Cytopathology.

Cytologic Findings on Experimental In Vivo Fallopian Tube Brush Specimens

R. M. Austin, E. Rodriguez, D. Lum, 2013 .

George Nicholas Papanicolaou: the unlikely story of an intellectual immigrant; one driven to contribute on a large stage; one who finally succeeded by scientifically inspiring numerous cooperating individuals and organizations

R. M. Austin, N. Chantziantoniou, R. Marshall Austin, 2014 .

HPV primary screening: unanswered questions

R. M. Austin, R. Marshall Austin, 2016, Cytopathology : official journal of the British Society for Clinical Cytology.

Increased cervical cancer risk associated with extended screening intervals after negative human papillomavirus test results: Bayesian risk estimates using the Pittsburgh Cervical Cancer Screening Model.

Agnieszka Onisko, R. Marshall Austin, R. M. Austin, 2016, Journal of the American Society of Cytopathology.

Who Should Decide How Effective Cervical Cancer Screening Will Be?

R. M. Austin, 1999, Acta Cytologica.

Opportunities for enhanced cervical and breast screening referral in Charleston County.

R. M. Austin, P. Baron, C. E. Gates, 1993, Journal of the South Carolina Medical Association.

Type 1 and type 2 cervical carcinomas: some cervical cancers are more difficult to prevent with screening

R. M. Austin, C. Zhao, 2012, Cytopathology : official journal of the British Society for Clinical Cytology.

Benign to malignant transformation in epithelial ovarian tumors.

R. M. Austin, 1993, Human pathology.